UCI Health a Gilead site for COVID-19 Drug Trials

UCI Health a Gilead site for COVID-19 Drug Trials

UCI Health’s medical complex in Orange will be the site of a therapeutic clinical trial for a drug that can treat the coronavirus. San Dimas-based Gilead Sciences this week said early studies indicate its drug remdesivir showed promise for this purpose; the U.S. FDA could authorize the drug’s use for coronavirus treatment if further clinical tries show effects on recovery time. … UCI’s trial is a double-blind study seeking 572 subjects. [Subscription required.]